文献库，生知库 | 链接生命科学的每一步

日期影响因子

Contemporary Nodal Management and Overall Survival of Older Patients with HR-/HER2+ Breast Cancer

现代淋巴结管理及老年HR-/HER2+乳腺癌患者的总生存期

期刊:Annals of Surgical Oncology

影响因子:3.5

doi:10.1245/s10434-025-18417-z

Cobb, Adrienne N; Dong, Xiaowei; Makope, Audrey; Cohen, Lauren; Huang, Chiang-Ching; Kong, Amanda L; Cortina, Chandler S

发表日期：2026

文献求助收藏

ASO Author Reflections: Prognostic and Therapeutic Implications of Nodal Burden in HER2-Positive Breast Cancer

ASO作者反思：淋巴结负荷在HER2阳性乳腺癌中的预后和治疗意义

期刊:Annals of Surgical Oncology

影响因子:3.5

doi:10.1245/s10434-025-18525-w

Cobb, Adrienne N; Cortina, Chandler S

发表日期：2026

文献求助收藏

Reply to: Letter to the Editor of Annals of Surgical Oncology Concerning "Evaluating Survival and Treatment Patterns Using the National Cancer Database in HER2-Positive Breast Cancer," by Sanli, Deniz et al

回复：Sanli、Deniz 等人致《外科肿瘤学年鉴》编辑的信函，内容关于“利用国家癌症数据库评估 HER2 阳性乳腺癌的生存率和治疗模式”

期刊:Annals of Surgical Oncology

影响因子:3.5

doi:10.1245/s10434-025-18797-2

Cobb, Adrienne N; Cortina, Chandler S

发表日期：2026

文献求助收藏

Correction: Contemporary Nodal Management and Overall Survival of Older Patients with HR-/HER2+ Breast Cancer

更正：HR-/HER2+乳腺癌老年患者的现代淋巴结管理和总生存期

期刊:Annals of Surgical Oncology

影响因子:3.5

doi:10.1245/s10434-025-18811-7

Cobb, Adrienne N; Dong, Xiaowei; Makope, Audrey; Cohen, Lauren; Huang, Chiang-Ching; Kong, Amanda L; Cortina, Chandler S

发表日期：2026

文献求助收藏

Does neoadjuvant systemic therapy in clinical T1-2 N0 human epidermal growth factor receptor 2-positive breast cancer increase the extent of axillary surgery?

对于临床 T1-2 N0 人表皮生长因子受体 2 阳性乳腺癌，新辅助全身治疗是否会增加腋窝手术的范围？

影响因子:2.7

doi:10.1016/j.surg.2025.109907

Rogers, Christine C; Cohen, Lauren N; Lloren, Jan Irene C; Huang, Chiang-Ching; Cobb, Adrienne N; Kong, Amanda L; Singh, Puneet; Teshome, Mediget; Cortina, Chandler S

发表日期：2026

文献求助收藏

From Podium to PubMed: Successful Manuscript Publication of Oral Breast Surgery Abstract Presentations at National Meetings from 2017 to 2022

从讲台到PubMed：2017年至2022年全国会议上口腔乳腺外科摘要报告成功发表的论文集

期刊:Annals of Surgical Oncology

影响因子:3.5

doi:10.1245/s10434-025-17852-2

Summerside, Margaret; Istl, Alexandra C; Rogers, Christine C; Cobb, Adrienne N; Kong, Amanda L; Singh, Puneet; Cortina, Chandler S

发表日期：2025

文献求助收藏

National trends in neoadjuvant systemic therapy utilization in patients with early-stage HER2-positive breast cancer from 2016-2021: The impact of the KATHERINE trial

2016-2021年早期HER2阳性乳腺癌患者新辅助全身治疗应用情况的全国趋势：KATHERINE试验的影响

期刊:Breast Cancer Research and Treatment

doi:10.1007/s10549-025-07750-2

Cohen, Lauren N; Rogers, Christine C; Lloren, Jan Irene C; Kamaraju, Sailaja; Chaudhary, Lubna N; Huang, Chiang-Ching; Cobb, Adrienne N; Singh, Puneet; Kong, Amanda L; Teshome, Mediget; Cortina, Chandler S

发表日期：2025

文献求助收藏

Current insights into breast and ovarian cancer risk: a contemporary review

当前对乳腺癌和卵巢癌风险的认识：一项当代综述

期刊:Minerva Surgery

影响因子:0.8

doi:10.23736/S2724-5691.25.10651-5

Gaughan, Natalie A; Rademacher, Nicole; Rogers, Christine; Purdy, Anna; Mattingly, Joanne D; Patten, Caitlin R; Cobb, Adrienne N; Kong, Amanda L; Cortina, Chandler S

发表日期：2025

文献求助收藏

Does Neoadjuvant Chemotherapy in Clinical T1-T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery?

新辅助化疗是否会增加临床 T1-T2 N0 三阴性乳腺癌腋窝手术的范围？

期刊:Annals of Surgical Oncology

影响因子:3.5

doi:10.1245/s10434-024-14914-9

Cortina, Chandler S; Lloren, Jan Irene; Rogers, Christine; Johnson, Morgan K; Cobb, Adrienne N; Huang, Chiang-Ching; Kong, Amanda L; Singh, Puneet; Teshome, Mediget

发表日期：2024

文献求助收藏

National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial

早期淋巴结阴性/三阴性乳腺癌患者新辅助化疗应用情况的全国趋势：CREATE-X试验的影响

期刊:Breast Cancer Research and Treatment

doi:10.1007/s10549-023-07114-8

Rogers, Christine; Cobb, Adrienne N; Lloren, Jan I C; Chaudhary, Lubna N; Johnson, Morgan K; Huang, Chiang-Ching; Teshome, Mediget; Kong, Amanda L; Singh, Puneet; Cortina, Chandler S

发表日期：2024

文献求助收藏